What amount sold does Emerging Therapy Solutions, Inc. report in Form D filings?

The latest linked filings report $24.3M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Emerging Therapy Solutions, Inc.'s most recent SEC filing?

Emerging Therapy Solutions, Inc.'s most recent Form D filing was on 2024-03-26.

How many investors does Emerging Therapy Solutions, Inc. have?

The most recent Form D filing lists 5 investor(s).

What type of securities does Emerging Therapy Solutions, Inc. offer?

Emerging Therapy Solutions, Inc.'s SEC Form D filings indicate equity offerings.

Emerging Therapy Solutions, Inc.

CIK: 0001763532·Other Health Care·BLOOMINGTON, MN·Corporation

Reported Sold

$24,287,128

Total Filings

Identified Offerings

Last Filed

Mar 26, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Mar 26, 2024Form D — New notice

Reported sold: $5,000,000 · Target: $5,000,000

Rule 506(b)·5 investors

Dec 20, 2022Form D — New notice

Reported sold: $3,000,000 · Target: Indefinite

Rule 506(b)·5 investors

Jun 7, 2021Form D — New notice

Reported sold: $6,004,725 · Target: Indefinite

Rule 506(b)·5 investors

Feb 11, 2021Form D — New notice

Reported sold: $1,000,000 · Target: $1,000,000

Rule 506(b)·5 investors

Feb 18, 2020Form D — New notice

Reported sold: $2,982,403 · Target: $2,982,403

Rule 506(b)·5 investors

May 22, 2019Form D — New notice

Reported sold: $1,000,000 · Target: $1,000,000

Rule 506(b)·1 investor

Jan 4, 2019Form D — New notice

Reported sold: $5,300,000 · Target: Indefinite

Rule 506(b)·4 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 7 identified offerings

$24,287,128

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kevin Roche

Related Person

Appears on 6 filings

Ravi Nalliah

Related Person

Appears on 5 filings

Jeanette Welsh

Related Person

Appears on 5 filings

J. Matthew Mackowski

Related Person

Appears on 5 filings

David McLean

Related Person

Appears on 5 filings

Gary Curtis

Related Person

Appears on 2 filings

Matt Mackowski

Related Person

Appears on 2 filings

Mike Burke

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 26, 2024	New	$5,000,000	$5,000,000	5
Dec 20, 2022	New	Indefinite	$3,000,000	5
Jun 7, 2021	New	Indefinite	$6,004,725	5
Feb 11, 2021	New	$1,000,000	$1,000,000	5
Feb 18, 2020	New	$2,982,403	$2,982,403	5
May 22, 2019	New	$1,000,000	$1,000,000	1
Jan 4, 2019	New	Indefinite	$5,300,000	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

PELVITAL USA, INC.

Other Health Care

Offering target: $4,000,000

Filed Oct 5, 2026